Prevalence and spectrum of p53 mutations associated with smoking in breast cancer

Cancer Research

Volumn 62, Issue 7, 2002, Pages 1987-1995

  Conway, Kathleen ^a   Edmiston, Sharon N ^a   Cui, Lisa ^a   Drouin, S Scott ^a   Pang, Jingzhong ^a   He, Mei ^a   Tse, Chiu Kit ^a   Geradts, Joseph ^a   Dressler, Lynn ^a   Liu, Edison T ^a   Millikan, Robert ^a   Newman, Beth ^a  

^a IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CIGARETTE SMOKING; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADULT; AGED; BREAST NEOPLASMS; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENES, P53; HUMANS; MIDDLE AGED; MUTATION; NORTH CAROLINA; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PREVALENCE; RISK FACTORS; SMOKING;

EID: 0036531921     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (99)

1. Proportion of breast cancer cases in the United States explained by well-established risk factors
2. Female lung cancer
3. Effect of cigarette smoking and alcohol consumption in the aetiology of cancer of the oral cavity and oropharynx among U. S. veterans
4. Carcinogenic effect of tobacco smoking and alcohol drinking on anatomic sites of the oral cavity and oropharynx
5. Epidemiology of bladder cancer
6. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients
7. p53 mutations in lung tumours: Relationship to gender and lung DNA adduct levels
8. Gender- and smoking-related bladder cancer risk
9. Race and sex differences in lung cancer risk associated with cigarette smoking
10. Are female smokers at higher risk for lung cancer than male smokers?
11. Differences in lung cancer risk between men and women: Examination of the evidence
12. Cigarette smoking and the risk of breast cancer
13. Cigarette smoking and breast cancer: A case-control study of screening program participants
14. Alcohol, cigarette smoking, and breast cancer
15. Cigarette smoking and breast cancer
16. Cigarette smoking and breast cancer
17. Smoking, menopause, and breast cancer
18. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk
19. Cigarette smoking and breast cancer
20. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk
21. Relation of breast cancer with passive and active exposure to tobacco smoke
22. Cigarette smoking increases risk for breast cancer in high-risk breast cancer families
23. Active and passive smoking and the occurrence of breast cancer
24. Breast cancer and cigarette smoking: A hypothesis
25. Breast cancer, cigarette smoking, and passive smoking
26. Cigarette smoking and the risk of breast cancer
27. Cigarette smoking, alcohol consumption and risk of breast cancer in young women
28. Cigarette smoking and the risk of breast cancer
29. Cancer incidence in female smokers: A 26-year follow-up
30. Prospective study of smoking and the risk of breast cancer
31. Alcohol, smoking, passive smoking, and caffeine in relation to breast cancer risk in young women
32. Cigarette smoking, alcohol consumption, and breast cancer risk
33. Socioeconomic characteristics, smoking, medical and family history, and breast cancer
34. Cigarette smoking and breast cancer risk among young women (United States)
35. Cigarette smoke and the hormonal receptor status in breast cancer
36. Effect of smoking on breast cancer in carriers of mutant BRCAI or BRCA2 genes
37. Increased 2-hydroxylation of estradiol as a possible mechanism for the anti-estrogenic effect of cigarette smoking
38. Cigarette smoking and urinary estrogens
39. Bone mass and the risk of breast cancer among postmenopausal women
40. The antiestrogenic effect of cigarette smoking in women
41. Relation between smoking and age of natural menopause
42. Smoking history and cancer patient survival: A hospital cancer registry study
43. Cigarette smoking and risk of fatal breast cancer
44. Genotoxicity of tobacco smoke and tobacco smoke condensate
45. Carcinogen biomarkers related to smoking and upper aerodigestive tract cancer
46. Tobacco smoke carcinogens and lung cancer
47. Metabolites of a tobacco-specific lung carcinogen in nonsmoking women exposed to environmental tobacco smoke
48. Polycyclic aromatic hydrocarbons in human fat and liver
49. Metabolism and activation of carcinogenic polycyclic hydrocarbons by human mammary cells
50. Environmental carcinogens that may be involved in human breast cancer etiology
51. DNA damage in breast epithelial cells: Detection by the single-cell gel (comet) assay and induction by human mammary lipid extracts
52. Mutagenic activity in nipple aspirates of human breast fluid
53. Aromatic DNA adducts in adjacent tissues of breast cancer patients: Clues to breast cancer etiology
54. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis
55. Does a genotoxic carcinogen contribute to human breast cancer? The value of mutational spectra in unraveling the aetiology of cancer
56. Molecular epidemiology of breast cancer
57. Prognostic significance of p53 gene alterations in node-negative breast cancer
58. Somatic mutations in the p53 gene and prognosis in breast cancer: A metaanalysis
59. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer
60. Prognostic value of p53 gene mutations in a large series of node-negative breast cancer patients
61. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy
62. Analysis of p53 gene mutation by polymerase chain reaction-single strand conformation polymorphism provides independent prognostic information in node-negative breast cancer
63. The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry
64. Distinct prognostic values of p53 mutations and loss of estrogen receptor and their cumulative effect in primary breast cancers
65. P53, the cellular gatekeeper for growth and division
66. A specific spectrum of p53 mutations in lung cancer from smokers: Review of mutations compiled in the IARC p53 database
67. The Carolina Breast Cancer Study: Integrating population-based epidemiology and molecular biology
68. Participation rates in a case-control study: The impact of age, race, and race of interviewer
69. Policy guidelines for the utilization of formalin-fixed, paraffin-embedded tissue sections: The UNC SPORE experience
70. P53 mutations in malignant gliomas
71. Alterations of the p16 gene in head and neck cancer: Frequency and association with p53, Prad-I and HPV
72. A high frequency of sequence alterations is due to formalin fixation of archival specimens
73. Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck
74. A dose-response relationship between the frequency of p53 mutations and tobacco consumption in lung cancer patients
75. Cigarette smoking and p53 mutations in lung cancer and bladder cancer
76. Molecular epidemiology of human cancer risk: Gene-environment interactions and p53 mutation spectrum in human lung cancer
77. Alcohol consumption and cigarette smoking increase the frequency of p53 mutations in non-small cell lung cancer
78. Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity at the FHIT locus
79. Preferential formation of benzo(a)pyrene adducts at lung cancer mutational hotspots in p53
80. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern
81. A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking, and occupational exposure to asbestos
82. Cigarette smoking and other risk factors in relation to p53 expression in breast cancer among young women
83. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: A molecular epidemiologic study
84. A study of tobacco carcinogenesis. X. Tumor promoting activity
85. Tobacco smoking
86. Cocarcinogenic and tumor-promoting agents in tobacco carcinogenesis
87. The tumor suppressor p53 is a negative regulator of estrogen receptor signaling pathways
88. p53 down-regulates ER-responsive genes by interfering with the binding of ER to ERE
89. Estrogen receptor protects p53 from deactivation by human double minute-2
90. Estradiol induces functional inactivation of p53 by intracellular redistribution
91. Cytoplasmic sequestration and functional repression of p53 in the mammary epithelium is reversed by hormonal treatment
92. The aryl hydrocarbon receptor interacts with estrogen receptor alpha and orphan receptors COUP-TFI and ERRα1
93. Diluted mainstream cigarette smoke condensates activate estrogen receptor and aryl hydrocarbon receptor-mediated gene transcription
94. Interactions of nuclear receptor coactivator/corepressor proteins with the aryl hydrocarbon receptor complex
95. p53 gene mutations and steroid receptor status in breast cancer
96. Prognostic significance of TP53 alterations in breast carcinoma
97. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer
98. Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis